SCHEMBL10328488

SCHEMBL10328488

COc1cc2nccc(Cc3ccc(NS(=O)(=O)c4ccc(OC)c(C(C)(C)C)c4)cc3)c2cc1OC

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
WDR5 P61964 1/20 0.53
AXL P30530 6/20 0.47
TSHR P16473 1/20 0.45
HTT P42858 3/20 0.44
NPSR1 Q6W5P4 2/20 0.44
LMNA P02545 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
CYP19A1 P11511 1/20 0.43
MEN1 O00255 1/20 0.43
ALOX15 P16050 1/20 0.43
MAPK1 P28482 1/20 0.43
KMT2A Q03164 1/20 0.43
ALDH1A1 P00352 2/20 0.42
POLB P06746 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
CA12 O43570 1/20 0.42
CA9 Q16790 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1592059 0.83 AXL (0.67) WDR5AXL
SCHEMBL13667265 0.80 PGR (0.54) AXL
SCHEMBL10328526 0.78 AXL (0.58) AXL
SCHEMBL13667683 0.75 KIT (0.45) AXL
SCHEMBL10328522 0.74 AXL (0.54) AXLHTTLMNAKMT2AALDH1A1
SCHEMBL13667276 0.73 LRRK2 (0.48) AXLLMNASMN1; SMN2
SCHEMBL13667281 0.73 LRRK2 (0.49) AXLHTTLMNASMN1; SMN2CA12
SCHEMBL11822901 0.72 PDE10A (0.58) TSHRHTTNPSR1LMNASMN1; SMN2
SCHEMBL10328520 0.72 AXL (0.57) AXLHTTNPSR1
SCHEMBL10328494 0.72 AXL (0.53) AXLTSHRNPSR1LMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2262772-B1 QUINOLINE DERIVATIVES AS AXL KINASE INHIBITORS MAX PLANCK GESELLSCHAFT (DE) 2012-07-18 EP disclosed
WO-2009127417-A1 QUINOLINE DERIVATIVES AS AXL KINASE INHIBITORS MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2009-10-22 WO disclosed